The role and potential of CD19-targeted chimeric antigen receptor T-cell therapy in systemic sclerosis
Systemic sclerosis (SSc) remains a challenge due to high mortality and resistance to treatment. Chimeric antigen receptor T-cell (CAR-T) technology (anti-CD19) may offer an opportunity for an immune system reset and long-term disease remission, eliminating the need for lifelong medication. This narrative rev...